Given that NAFLD represents a multifactorial disease entity, additional determinants, such as socioeconomic status, dietary patterns, physical activity, medication regimens, socioeconomic status, and hepatic enzyme profiles beyond conventional ALT and AST measurements, as well as longitudinal changes in both BMI and waist circumference, may substantially influence both eGDR and fibrosis progression. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.